OBJECTIVES: To demonstrate that high IQ adults diagnosed with ADHD suffer from executive function (EF) impairments that: a) can be identified with a combination of standardized measures and self-report data; and b) occur more commonly in this group than in the general population. METHOD: 157 ADHD adults with IQ >/= 120 were assessed with 8 normed measures of EF- 3 index scores from standardized tests of memory and cognitive abilities, and 5 subscales of a normed self-report measure of EF impairments in daily life. RESULTS: 73% of subjects were significantly impaired on >/= 5 of these 8 EF markers. On all 8 measures, incidence of these impairments was significantly greater than in the general population. CONCLUSION: High IQ adults with ADHD tend to suffer EF impairments that can be assessed with these measures; incidence of such impairments in this group is significantly higher than in the general population.
OBJECTIVES: To demonstrate that high IQ adults diagnosed with ADHD suffer from executive function (EF) impairments that: a) can be identified with a combination of standardized measures and self-report data; and b) occur more commonly in this group than in the general population. METHOD: 157 ADHD adults with IQ >/= 120 were assessed with 8 normed measures of EF- 3 index scores from standardized tests of memory and cognitive abilities, and 5 subscales of a normed self-report measure of EF impairments in daily life. RESULTS: 73% of subjects were significantly impaired on >/= 5 of these 8 EF markers. On all 8 measures, incidence of these impairments was significantly greater than in the general population. CONCLUSION: High IQ adults with ADHD tend to suffer EF impairments that can be assessed with these measures; incidence of such impairments in this group is significantly higher than in the general population.
Authors: Lenard A Adler; Stephen V Faraone; Thomas J Spencer; Patricia Berglund; Samuel Alperin; Ronald C Kessler Journal: Int J Methods Psychiatr Res Date: 2017-02-17 Impact factor: 4.035
Authors: C Neill Epperson; Sheila Shanmugan; Deborah R Kim; Sarah Mathews; Kathryn A Czarkowski; Jeanette Bradley; Dina H Appleby; Claudia Iannelli; Mary D Sammel; Thomas E Brown Journal: Psychopharmacology (Berl) Date: 2015-06-11 Impact factor: 4.530
Authors: Jane A Sedgwick-Müller; Ulrich Müller-Sedgwick; Marios Adamou; Marco Catani; Rebecca Champ; Gísli Gudjónsson; Dietmar Hank; Mark Pitts; Susan Young; Philip Asherson Journal: BMC Psychiatry Date: 2022-04-22 Impact factor: 4.144